Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
131 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Ali Zedan Tohamy mohammed 2021
132 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2021
133 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Department of Pediatric Oncology Dr. Ahmed Mohammed Morsy Hassan 2021
134 Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute Department of Pediatric Oncology Dr. Aminh Naje Abdul Hameed Jad Elarab 2021
135 Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin Department of Anesthesia, Intensive care and Pain management Dr. Shereen Mamdoh Mohamed kamal 2021
136 Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
137 Assessment of Humoral Immune Recovery in Children with Hematological malignancies after Completion of Chemotherapy Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2021
138 The role of quantitative computed tomography perfusion in the assessment of colorectal thickening Department of Medical Oncology Dr. Adel Gomaa Mohamed Gabr 2021
139 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Department of Medical Oncology Matta Gerges Mounir Meshreky 2021
140 Role of post-therapy 99mTc-MIBI single-photon emission computed tomography/computed tomography scan in predicting survival in patients with high-grade glioma Department of Radiotherapy and Nuclear medicine Dr. Esraa Roshdy Hassan Mohamed 2021